Literature DB >> 8632908

Nerve growth factor-induced accumulation of PC12 cells expressing cyclin D1: evidence for a G1 phase block.

L A van Grunsven1, A Thomas, J L Urdiales, S Machenaud, P Choler, I Durand, B B Rudkin.   

Abstract

The anti-proliferative effect of nerve growth factor (NGF) on the rat pheochromocytoma cell line PC12 has been previously shown to be accompanied by the accumulation of cells in either the G1 phase with a 2c DNA content, or with a 4c DNA content characteristic for G2/M, as evidenced by flow cytometric analysis of DNA distribution using propidium iodide. Herein, these apparently conflicting results are clarified. The present studies indicate that a simple DNA distribution profile obtained by this technique can confound interpretation of the biological effects of NGF on cell-cycle distribution due to the presence of tetraploid cells. Using cyclin D1 and incorporation of bromodeoxyuridine as markers of respectively, G1 and S phase, we show that PC12 cultures can have a considerable amount of tetraploid cells which, when in the G1 phase, have a 4c DNA content and express cyclin D1. During exposure to NGF, this population increases, reflecting the accumulation of cells in the G1 phase of the cell cycle. The data presented, support the possibility that events affecting the expression or action of G1 regulatory proteins may be involved in the molecular mechanism of the anti-mitogenic effect of NGF.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632908

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.

Authors:  T Goi; G Rusanescu; T Urano; L A Feig
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Nerve growth factor induces cell cycle arrest of astrocytes.

Authors:  Andrea B Cragnolini; Marta Volosin; Yangyang Huang; Wilma J Friedman
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

3.  Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor.

Authors:  K Ye; D A Compton; M M Lai; L D Walensky; S H Snyder
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

4.  Role of cyclins in neuronal differentiation of immortalized hippocampal cells.

Authors:  W Xiong; R Pestell; M R Rosner
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

5.  Ebp1 isoforms distinctively regulate cell survival and differentiation.

Authors:  Zhixue Liu; Jee-Yin Ahn; Xia Liu; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-10       Impact factor: 11.205

6.  Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells.

Authors:  M Meyyappan; H Wong; C Hull; K T Riabowol
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

7.  Proliferation and differentiation of neural stem cells are selectively regulated by knockout of cyclin D1.

Authors:  Junfang Ma; Zhiyuan Yu; Wensheng Qu; Yingxin Tang; Yan Zhan; Can Ding; Wei Wang; Minjie Xie
Journal:  J Mol Neurosci       Date:  2010-05-01       Impact factor: 3.444

8.  Cell cycle phase-specific surface expression of nerve growth factor receptors TrkA and p75(NTR).

Authors:  J L Urdiales; E Becker; M Andrieu; A Thomas; J Jullien; L A van Grunsven; S Menut; G I Evan; D Martín-Zanca; B B Rudkin
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

9.  CD38/cADPR/Ca2+ pathway promotes cell proliferation and delays nerve growth factor-induced differentiation in PC12 cells.

Authors:  Jianbo Yue; Wenjie Wei; Connie M C Lam; Yong-Juan Zhao; Min Dong; Liang-Ren Zhang; Li-He Zhang; Hon-Cheung Lee
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

10.  Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle.

Authors:  Marçal Vilar; Maribel Murillo-Carretero; Helena Mira; Kalle Magnusson; Valerie Besset; Carlos F Ibáñez
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.